• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大鼠体内4-甲基伞形酮结合代谢产物的膜限制性肝转运

Membrane-limited hepatic transport of the conjugative metabolites of 4-methylumbelliferone in rats.

作者信息

Miyauchi S, Sugiyama Y, Iga T, Hanano M

机构信息

Faculty of Pharmaceutical Sciences, University of Tokyo, Japan.

出版信息

J Pharm Sci. 1988 Aug;77(8):688-92. doi: 10.1002/jps.2600770809.

DOI:10.1002/jps.2600770809
PMID:3210158
Abstract

The hepatic transports of 4-methylumbelliferone (4-MU) and its conjugative metabolites, the glucuronide (4-MUG) and sulfate (4-MUS), were investigated in rats with various methods. The extraction ratio (E) was estimated with the multiple indicator dilution (MID) method using isolated perfused rat liver. The values of E for 4-MUG and 4-MUS were much lower (less than 0.2) than that for the parent compound, 4-MU (0.89). In addition, we examined the simulation of the outflow curves of conjugates based on the "distributed" model in which we varied the permeability between the blood and hepatocytes. When the permeability was much smaller relative to the hepatic blood flow, the simulated curve was superimposed on the dilution curve. These results suggest that the influx permeabilities of these conjugates are so low that little extraction occurs during the passage through the liver. Measuring the unidirectional uptake of these conjugates into the liver with the in vitro centrifugal filtration method using isolated hepatocytes, we determined the influx permeabilities (PSinf(total] for the total ligands. The value of PSinf(total) determined with the in vitro method was extrapolated to that per gram of liver, assuming 1 g of liver has 1.3 X 10(8) cells. The values of PSinf(total) for 4-MU, 4-MUG, and 4-MUS were 4.8, 0.06, and 0.11 mL/min/g liver, respectively. Thus, the influx permeabilities for 4-MUG and 4-MUS were much smaller than the hepatic blood flow (1.6 mL/min/g liver), confirming the results of MID method.

摘要

采用多种方法对大鼠体内4-甲基伞形酮(4-MU)及其结合代谢产物葡萄糖醛酸苷(4-MUG)和硫酸酯(4-MUS)的肝脏转运进行了研究。使用离体灌注大鼠肝脏,通过多指示剂稀释(MID)法估算提取率(E)。4-MUG和4-MUS的E值(小于0.2)远低于母体化合物4-MU的E值(0.89)。此外,我们基于“分布”模型对结合物流出曲线进行了模拟,在该模型中改变了血液与肝细胞之间的通透性。当通透性相对于肝血流量小得多时,模拟曲线与稀释曲线重叠。这些结果表明,这些结合物的流入通透性很低,以至于在通过肝脏的过程中几乎没有提取发生。使用离体肝细胞通过体外离心过滤法测量这些结合物向肝脏的单向摄取,我们确定了总配体的流入通透性(PSinf(total))。假设1 g肝脏含有1.3×10(8)个细胞,将体外方法测定的PSinf(total)值外推至每克肝脏的值。4-MU、4-MUG和4-MUS的PSinf(total)值分别为4.8、0.06和0.11 mL/min/g肝脏。因此,4-MUG和4-MUS的流入通透性远小于肝血流量(1.6 mL/min/g肝脏),证实了MID法的结果。

相似文献

1
Membrane-limited hepatic transport of the conjugative metabolites of 4-methylumbelliferone in rats.大鼠体内4-甲基伞形酮结合代谢产物的膜限制性肝转运
J Pharm Sci. 1988 Aug;77(8):688-92. doi: 10.1002/jps.2600770809.
2
The conjugative metabolism of 4-methylumbelliferone and deconjugation to the parent drug examined by isolated perfused liver and in vitro liver homogenate of rats.
Chem Pharm Bull (Tokyo). 1989 Feb;37(2):475-80. doi: 10.1248/cpb.37.475.
3
Kinetics of hepatic transport of 4-methylumbelliferone in rats. Analysis by multiple indicator dilution method.大鼠肝脏对4-甲基伞形酮的转运动力学。采用多指示剂稀释法进行分析。
J Pharmacokinet Biopharm. 1987 Feb;15(1):25-38. doi: 10.1007/BF01062937.
4
Comparison of the hepatic uptake clearances of fifteen drugs with a wide range of membrane permeabilities in isolated rat hepatocytes and perfused rat livers.在分离的大鼠肝细胞和灌注的大鼠肝脏中,对十五种具有广泛膜通透性的药物的肝脏摄取清除率进行比较。
Pharm Res. 1993 Mar;10(3):434-40. doi: 10.1023/a:1018952709120.
5
Conjugative metabolism of 4-methylumbelliferone in the rat liver: verification of the sequestration process in multiple indicator dilution experiments.大鼠肝脏中4-甲基伞形酮的结合代谢:多指示剂稀释实验中隔离过程的验证
Chem Pharm Bull (Tokyo). 1987 Oct;35(10):4241-8. doi: 10.1248/cpb.35.4241.
6
Futile cycling between 4-methylumbelliferone and its conjugates in perfused rat liver.4-甲基伞形酮与其共轭物在灌注大鼠肝脏中的无效循环。
Hepatology. 1993 May;17(5):838-53.
7
Pharmacokinetic study of 4-methylumbelliferone in rats: influence of dose on its first-pass hepatic elimination.4-甲基伞形酮在大鼠体内的药代动力学研究:剂量对其肝脏首过消除的影响。
J Pharmacobiodyn. 1986 Feb;9(2):117-24. doi: 10.1248/bpb1978.9.117.
8
Glucuronidation and sulfation in the rat in vivo. The role of the liver and the intestine in the in vivo clearance of 4-methylumbelliferone.大鼠体内的葡萄糖醛酸化和硫酸化。肝脏和肠道在4-甲基伞形酮体内清除中的作用。
Biochem Pharmacol. 1985 Apr 15;34(8):1325-9. doi: 10.1016/0006-2952(85)90513-1.
9
Carrier-mediated active transport of the glucuronide and sulfate of 6-hydroxy-5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl) benzothiazole (E3040) into rat liver: quantitative comparison of permeability in isolated hepatocytes, perfused liver and liver in vivo.6-羟基-5,7-二甲基-2-甲氨基-4-(3-吡啶甲基)苯并噻唑(E3040)的葡糖醛酸苷和硫酸盐经载体介导的主动转运进入大鼠肝脏:分离的肝细胞、灌注肝脏及活体肝脏中通透性的定量比较
J Pharmacol Exp Ther. 1997 Feb;280(2):948-58.
10
Carrier-mediated entry of 4-methylumbelliferyl sulfate: characterization by the multiple-indicator dilution technique in perfused rat liver.载体介导的硫酸4-甲基伞形酮的摄取:采用多指示剂稀释技术在灌注大鼠肝脏中的特性研究
Hepatology. 1998 Jan;27(1):134-46. doi: 10.1002/hep.510270122.

引用本文的文献

1
Disposition of flavonoids via recycling: Direct biliary excretion of enterically or extrahepatically derived flavonoid glucuronides.通过循环对黄酮类化合物的处置:肠道或肝外来源的黄酮类葡萄糖醛酸苷的直接胆汁排泄。
Mol Nutr Food Res. 2016 May;60(5):1006-19. doi: 10.1002/mnfr.201500692. Epub 2016 Apr 13.
2
Dietary supplement 4-methylumbelliferone: an effective chemopreventive and therapeutic agent for prostate cancer.膳食补充剂4-甲基伞形酮:一种有效的前列腺癌化学预防和治疗剂。
J Natl Cancer Inst. 2015 Apr 13;107(7). doi: 10.1093/jnci/djv085. Print 2015 Jul.
3
Stereoselective hepatic disposition of model diastereomeric acyl glucuronides.
模型非对映体酰基葡萄糖醛酸苷的立体选择性肝脏处置
J Pharmacokinet Pharmacodyn. 2004 Feb;31(1):1-27. doi: 10.1023/b:jopa.0000029486.60317.25.
4
Membrane transport in hepatic clearance of drugs. I: Extended hepatic clearance models incorporating concentration-dependent transport and elimination processes.
Pharm Res. 1997 Jun;14(6):774-9. doi: 10.1023/a:1012106623696.
5
Hepatic conjugation/deconjugation cycling pathways. Computer simulations examining the effect of Michaelis-Menten parameters, enzyme distribution patterns, and a diffusional barrier on metabolite disposition.肝脏结合/去结合循环途径。研究米氏参数、酶分布模式和扩散屏障对代谢物处置影响的计算机模拟。
J Pharmacokinet Biopharm. 1996 Apr;24(2):219-43. doi: 10.1007/BF02353490.
6
Comparison of the hepatic uptake clearances of fifteen drugs with a wide range of membrane permeabilities in isolated rat hepatocytes and perfused rat livers.在分离的大鼠肝细胞和灌注的大鼠肝脏中,对十五种具有广泛膜通透性的药物的肝脏摄取清除率进行比较。
Pharm Res. 1993 Mar;10(3):434-40. doi: 10.1023/a:1018952709120.
7
Formed and preformed metabolite excretion clearances in liver, a metabolite formation organ: studies on enalapril and enalaprilat in the single-pass and recirculating perfused rat liver.肝脏(一种代谢物生成器官)中已生成和预先形成的代谢物排泄清除率:关于依那普利和依那普利拉在单次通过和再循环灌注大鼠肝脏中的研究
J Pharmacokinet Biopharm. 1993 Aug;21(4):395-422. doi: 10.1007/BF01061689.